David P. Luci
President and CEO at Acurx Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Acurx Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Acurx Pharmaceuticals Inc. June 15, 202393.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 2025 | Acurx Pharmaceuticals Inc. | Open-market purchase | +49,261 | $1.02 | $50,246 |
| Jan 3, 2024 | Acurx Pharmaceuticals Inc. | Option exercise | +19,737 | $3.55 | $70,066 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.